Literature DB >> 7536413

A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes.

A Savage1, L Zeng, M D Houslay.   

Abstract

An immobilized hepatocyte preparation was used to show that both vasopressin and glucagon could desensitize the ability of glucagon to increase intracellular cyclic AMP concentrations. This process was not dependent on any influx of extracellular Ca2+ and was not mediated by any rise in the intracellular level of Ca2+. The protein kinase C-selective inhibitors chelerythrine, staurosporine and calphostin C acted as potent inhibitors of the desensitization process but with various degrees of selectivity regarding their ability to inhibit the desensitizing actions of glucagon and vasopressin. The protein phosphatase inhibitor okadaic acid was just as potent as vasopressin and glucagon in causing desensitization. Treatment of hepatocyte membranes with alkaline phosphatase restored to near control levels the ability of glucagon to stimulate adenylate cyclase activity in membranes from both glucagon- and vasopressin-treated (desensitized) hepatocytes. It is suggested that the desensitization of glucagon-stimulated adenylate cyclase activity involves a reversible phosphorylation reaction with the likely target being the glucagon receptor itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536413      PMCID: PMC1136774          DOI: 10.1042/bj3070281

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity.

Authors:  E K Tang; M D Houslay
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

Review 2.  Molecular mechanisms of membrane receptor desensitization.

Authors:  M J Lohse
Journal:  Biochim Biophys Acta       Date:  1993-11-07

3.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

5.  The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.

Authors:  M D Houslay; J C Metcalfe; G B Warren; T R Hesketh; G A Smith
Journal:  Biochim Biophys Acta       Date:  1976-06-17

Review 6.  The nature and mechanism of activation of the hepatocyte receptor-activated Ca2+ inflow system.

Authors:  G J Barritt; B P Hughes
Journal:  Cell Signal       Date:  1991       Impact factor: 4.315

7.  Multi-site phosphorylation of the inhibitory guanine nucleotide regulatory protein Gi-2 occurs in intact rat hepatocytes.

Authors:  N J Morris; M Bushfield; B E Lavan; M D Houslay
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

Review 8.  Calcium: its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists.

Authors:  F L Bygrave; A Benedetti
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Activation of membrane protein kinase C by glucagon and Ca(2+)-mobilizing hormones in cultured rat hepatocytes. Role of phosphatidylinositol and phosphatidylcholine hydrolysis.

Authors:  R A Pittner; J N Fain
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

10.  Okadaic acid identifies a phosphorylation/dephosphorylation cycle controlling the inhibitory guanine-nucleotide-binding regulatory protein Gi2.

Authors:  M Bushfield; B E Lavan; M D Houslay
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

View more
  9 in total

Review 1.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

2.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Co-transfection with protein kinase D confers phorbol-ester-mediated inhibition on glucagon-stimulated cAMP accumulation in COS cells transfected to overexpress glucagon receptors.

Authors:  E S Tobias; E Rozengurt; J M Connell; M D Houslay
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise.

Authors:  Alexandre Charbonneau; Cecilia G Unson; Jean-Marc Lavoie
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

Review 5.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 6.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

7.  Characterization of neurosteroid effects on hyperpolarizing current at α4β2δ GABAA receptors.

Authors:  Qi Hua Gong; Sheryl S Smith
Journal:  Psychopharmacology (Berl)       Date:  2014-04-17       Impact factor: 4.530

8.  Insulin and vasopressin elicit inhibition of cholera-toxin-stimulated adenylate cyclase activity in both hepatocytes and the P9 immortalized hepatocyte cell line through an action involving protein kinase C.

Authors:  L Zeng; M D Houslay
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

9.  Pituitary adenylate cyclase-activating polypeptide induces expression of corticosteroid-binding globulin in cultured fetal hepatocytes: synergy with tri-iodothyronine.

Authors:  E el Fahime; B Lutz-Bucher; J M Felix; B Koch
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.